Emerging therapies for inherited retinal degeneration.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 27928030)

Published in Sci Transl Med on December 07, 2016

Authors

Hendrik P N Scholl1,2, Rupert W Strauss2,3,4,5,6, Mandeep S Singh2, Deniz Dalkara7,8,9, Botond Roska10,11, Serge Picaud7,8,9, José-Alain Sahel7,8,9,12,13,14

Author Affiliations

1: Department of Ophthalmology, University of Basel, 4056 Basel, Switzerland. hendrik.scholl@usb.ch.
2: Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287, USA.
3: Moorfields Eye Hospital, London EC1V 2PD, U.K.
4: UCL Institute of Ophthalmology, University College London, London EC1V 9EL, U.K.
5: Department of Ophthalmology, Medical University Graz, Graz, Austria.
6: Department of Ophthalmology, Johannes Kepler University Linz, 4021 Linz, Austria.
7: INSERM, UMR S 968, 75012 Paris, France.
8: Sorbonne Universités, UPMC Univ Paris 06, Institut de la Vision, Paris, France.
9: CNRS, UMR 7210, 75012 Paris, France.
10: Department of Ophthalmology, University of Basel, 4056 Basel, Switzerland.
11: Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
12: Fondation Ophtalmologique Adolphe de Rothschild, 75019 Paris, France.
13: Centre d'Investigation Clinique 1423, INSERM-Center Hospitalier National d'Ophtalmologie des Quinze-Vingts, 75012 Paris, France.
14: Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.